Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 53, 2023 - Issue 3
258
Views
8
CrossRef citations to date
0
Altmetric
Articles

One-pot synthesis and antibacterial screening of new (nicotinonitrile-thiazole)-based mono- and bis(Schiff bases) linked to arene units

, ORCID Icon & ORCID Icon
Pages 245-261 | Received 25 Aug 2022, Published online: 02 Jan 2023
 

Abstract

Two series of (nicotinonitrile-thiazole)-based Schiff bases 1 and their bis(Schiff bases) analogs 2 are efficiently prepared in this study. A one-pot protocol was designed to prepare the target products involved the reaction of the respective nicotinonitrile-based salicylaldehyde, thiosemicarbazide, and the appropriate mono- or bis(α-haloketones). The reaction was heated at 100 °C for 5–8 h in dioxane and mediated by triethylamine to produce the target hybrids in 80–92% yields. Generally, the (nicotinonitrile-thiazole)-based Schiff bases 1 demonstrated superior antibacterial activity over their bis(Schiff bases) analogs 2. The antibacterial activity of Schiff bases 1d and 1e linked to p-tolyl and 4-methoxyphenyl units was the best against Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa strains. They had MIC and MBC values ranging from 3.8 to 4.0 and 7.7 to 8.0 µM, respectively. Using SwissADME to predict the physicochemical properties, lipophilicity, and drug-likeness of new products, Schiff bases 1 can be considered as drug-like scaffolds.

Graphical abstract

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.